id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0230-0013,FDA,FDA-2011-N-0230,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval Examination of Online Direct-to-Consumer Prescription Drug Promotion,Notice,Notice of Approval,2012-07-19T04:00:00Z,2012,7,,,2012-07-19T13:10:29Z,2012-17554,0,0,09000064810a43f0
FDA-2011-N-0230-0011,FDA,FDA-2011-N-0230,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Examination of Online Direct-to-Consumer Prescription Drug Promotion",Notice,General Notice,2011-12-19T05:00:00Z,2011,12,2011-12-19T05:00:00Z,2012-01-19T04:59:59Z,2012-03-24T19:36:35Z,2011-32275,0,0,0900006480f858fb
FDA-2011-N-0230-0007,FDA,FDA-2011-N-0230,See FDA-2011-N-0230-0006,Supporting & Related Material,Historical Information (HIST),2011-07-19T04:00:00Z,2011,7,,,2011-07-19T16:09:37Z,,0,0,0900006480eb5d0e
FDA-2011-N-0230-0010,FDA,FDA-2011-N-0230,"Reference 1 - Macias, W. and L. Stavchansky Lewis, ""How Well Do Direct-to-Consumer (DTC) Prescription Drug Web Sites Meet FDA Guildlines and Public Policy Concers?"" Health Marketing Quarterly, vol.22, pp. 45-71, 2005 re FDA-2011-N-0230-0001",Supporting & Related Material,Reference (internal unless indicated),2011-07-19T04:00:00Z,2011,7,,,2011-07-19T16:27:59Z,,0,0,0900006480c3bcd9
FDA-2011-N-0230-0001,FDA,FDA-2011-N-0230,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Examination of Online Direct-to-Consumer Prescription Drug Promotion",Notice,N-Notice,2011-04-28T04:00:00Z,2011,4,2011-04-28T04:00:00Z,2011-06-28T03:59:59Z,2011-04-28T14:56:12Z,2011-10253,0,0,0900006480c3b60c